Revenue segments as reported by the company.

Pharmacy revenues

Premiums

Fees and other revenues

Net investment income

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Pharmacy and other service costs

Medical costs and other benefit expenses

Selling, general and administrative expenses

Amortization of acquired intangible assets

Special items

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Cigna

Express Scripts is a company that provides integrated pharmacy benefit management services including network-pharmacy claims processing; home delivery pharmacy services; specialty pharmacy benefit management, through its subsidiary Accredo; benefit-design consultation; drug-utilization review; formulary management; and medical and drug data analysis services to manage drug plans for health plans, self-insured employers and government agencies (both as administrator of employee benefits and public assistance programs). Express Scripts also offers pharmacy benefit management services for workers' compensation insurance programs. The program is accredited by URAC, the nation's largest accrediting body for pharmacy benefit management companies. The company processes pharmaceutical claims for members through a network of retail pharmacies. Its own automated pharmacies dispense long-term, chronic medications-like those for diabetes or heart disease-directly to members by home delivery.

Express Scripts

The Cigna Group is a global health company, which engages in the provision of global health services. It operates through the following segments: Evernorth Health Services, Cigna Healthcare, Other Operations, and Corporate. The Evernorth Health Services segment partners with health plans, employers, governmental organizations, and health care providers to solve challenges in the areas of pharmacy benefits, home delivery pharmacy, specialty pharmacy, specialty distribution, and care delivery and management solutions. The Cigna Healthcare segment includes the U.S. Healthcare and International Health operating segments, which provide comprehensive medical and coordinated solutions to clients and customers. The Other Operations segment consists of the remainder of business operations, which includes certain ongoing businesses and exited businesses. The Corporate segment refers to net interest expense, certain litigation matters, expense associated with frozen pension plans, charitable contributions, operating severance, certain overhead and enterprise-wide project costs, and eliminations for products and services sold between segments. The company was founded in 1792 and is headquartered in Bloomfield, CT.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Cigna posts strong Q4 earnings, eyes growth in specialized services

Cigna delivered strong financial results in Q4 2022, with robust revenue growth and operational performance across key business segments.
While facing challenges such as margin pressures and potential disenrollment, Cigna is well-positioned to capitalize on growth opportunities in 2023.
Strategic partnerships, customer-focused strategies, and financial discipline underscore Cigna's commitment to sustainable growth and shareholder value creation.
Investments in innovation, care coordination, and market expansion signal a proactive approach to navigating industry dynamics and driving future success.

Cigna reports robust Q1 earnings, eyes growth amid challenges

Cigna's Q1 2023 showcased strong financials, growth in key segments, and increased outlook.
Challenges include economic softening impact and margin expectations for the year.
Opportunities lie in customer relationships, innovation, and market-specific strategies.
Overall, Cigna remains confident in delivering on its financial and growth targets.

Cigna reports robust Q2 results, eyes growth through innovation

Cigna's Q2 2023 performance was strong, with revenue growth, customer expansion, and technological advancements driving positive outcomes.
While facing challenges like disenrollment and risk adjustment payables, Cigna is leveraging strengths in technology and cross-selling for growth.
Opportunities lie in partnerships like VillageMD, continued innovation, and strategic bidding strategies for future growth.
Overall, Cigna remains confident in delivering on adjusted EPS outlook for 2023 and 2024, with a focus on innovation and growth.

Cigna surpasses Q3 expectations, eyes $28 EPS in 2024

Cigna's Q3 performance exceeded expectations, driven by strong revenue and EPS growth across key business segments.
Strategic focus on innovation, affordability, and client partnerships positions Cigna well for future growth and value creation.
Challenges in margin expectations and enrollment declines require proactive management and strategic decision-making.
Opportunities lie in continued growth projections, strategic investments, and enhancing healthcare affordability and accessibility.

Cigna reports robust Q4 performance, eyes growth amid strategic changes

Cigna Group's Q4 2023 Earnings Call highlighted strong financial performance, leadership changes, and strategic decisions. Analyst inquiries focused on growth drivers, market outlook, and internal healthcare spend management. The outlook for 2024 includes expectations of solid adjusted EPS, revenue growth, and operating cash flow.

Cigna surpasses Q1 expectations, eyes growth through AI and biosimilars

Cigna's Q1 performance exceeded expectations, driven by strong revenue and EPS figures.
Despite challenges like noncash losses and disruptions, Cigna's strategic strengths in AI, biosimilars, and value-based care position it well for growth.
Opportunities in AI-driven healthcare solutions, biosimilar expansions, and strategic M&A offer avenues for future growth.
Cigna's focus on precision care solutions and client outcomes showcases its commitment to innovation and efficiency.

Cigna (CI) posts robust Q2 results, eyes biosimilar growth

Cigna (CI) reports strong Q2 financial results driven by Evernorth Health Services and Express Scripts' innovative programs.
Focus on affordability, access, and behavioral health services propels growth in U.S. employer business.
Challenges include navigating healthcare cost pressures and ensuring fair pricing negotiations.
Opportunities lie in biosimilar growth, sustainable revenue outlook, and strategic Medicare Advantage business sale.

Cigna reports robust Q3 earnings, eyes growth opportunities in 2025

Cigna's Q3 earnings call highlighted strong financial performance, strategic focus on shareholder value, and challenges in specialty drugs and cost trends. The company is optimistic about opportunities in 2025 and remains committed to delivering shareholder value through strategic initiatives.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Advance Auto Parts

Ball Corp

Best Buy

Domino's Pizza

Home Depot

Lowe's

Mastercard

Morgan Stanley

MSCI

SS&C Technologies Hlds

T. Rowe Price Group

Tractor Supply

Visa

I present my top 15 high-growth dividend stocks to consider during the month of September. The watchlist posted a loss of 4.88% in August and is now down 12.85% year-to-date.

My Top 15 High Growth Dividend Stocks For September 2022

The estate of Chuck Close, the artist known for massive photorealist portraits of himself and others, on Wednesday sued Cigna Corp, claiming it failed to pay hundreds of thousands of dollars for necessary medical care in the final years of his life.

Chuck Close's estate sues Cigna for not paying his medical benefits

Cigna (CI) unveils enhanced individual and family health plans for its customers to opt for in the 2023 Open Enrollment Period. CI will enter newer counties and states to offer better health outcomes.

Cigna (CI) to Widen Access to Individual Health Plans in 2023

When a stock breaks out above the 20-day simple moving average, good things could be on the horizon. How should investors react?

Cigna (CI) Just Overtook the 20-Day Moving Average

Cigna (CI) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Here is What to Know Beyond Why Cigna Corporation (CI) is a Trending Stock

BLOOMFIELD, Conn. , Aug. 30, 2022 /PRNewswire/ -- Global health services company Cigna Corporation (NYSE:CI) announced that health care industry leader Dr. David Brailer, M.D.

Dr. David Brailer, M.D., Ph.D. Joins Cigna as Executive Vice President and Chief Health Officer

Expansion includes presence in three new states and 50 new counties Plan features include new virtual primary care through MDLIVE, expanded $0 benefit options, and cost-effective prescription drugs BLOOMFIELD, Conn. , Aug. 29, 2022 /PRNewswire/ -- Cigna (NYSE: CI) will provide more customers and communities access to affordable, predictable, and simple health care coverage in 2023 by expanding the reach of its ACA Marketplace exchange plans.

Cigna Grows ACA Marketplace Presence, Giving More Customers and Communities Access to Quality, Cost-Effective Care

Cigna plans to grow its business of selling individual Obamacare coverage under the Affordable Care Act for 2023 to three new states.

Cigna Will Expand Obamacare Plans To Three New States

Cigna is a leading company in the health insurance industry.

Is This Sizzling Dividend Stock a Buy?

Funding will help therapists offer in-network care in all 50 states NEW YORK , Aug. 25, 2022 /PRNewswire/ --  Alma , a membership-based network that helps independent mental health care providers accept insurance and build thriving private practices, has announced $130 million in Series D funding led by Thoma Bravo, a leading software investment firm, with participation from Cigna Ventures. Existing investors Insight Partners, Optum Ventures, Tusk Venture Partners, Primary Venture Partners, and Sound Ventures also participated in the round, bringing the company's total funding to over $220 million.

Alma Raises $130M in Series D Funding led by Thoma Bravo to Advance its Mission to Simplify Access to High Quality, Affordable Mental Health Care

BLOOMFIELD, Conn. , Aug. 23, 2022 /PRNewswire/ -- Global health services company Cigna Corporation (NYSE: CI) announced today that David Cordani, chairman and chief executive officer, will present at the Morgan Stanley 20th Annual Global Healthcare Conference on September 13, 2022 in New York, NY.

Cigna Corporation Announces Appearance at the Morgan Stanley 20th Annual Global Healthcare Conference

Athene Holding Ltd. Class A

Brookfield Asset Management

Blackstone Group

Markel

Progressive

Travelers

UnitedHealth Group

Growing interest rates are a major tailwind for insurers. It is not accidental that Warren Buffett recently made a big insurance acquisition after a long dry spell. Even at low interest rates, six insurers presented have delivered index-beating returns.

My 6 Warren Buffett-Inspired Insurance Picks

Cigna (CI) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

All You Need to Know About Cigna (CI) Rating Upgrade to Buy

Cigna (CI) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Is Trending Stock Cigna Corporation (CI) a Buy Now?

Advanced Micro Devices

Moderna

ServiceNow

NVIDIA

Tesla

Uber

Vertex Pharmaceuticals

Sales growth is a very important financial metric that investors consider before making a buy decision.

These Are The Biggest Companies with Over 30% Sales Growth

Over the past decade, Cigna Corporation ( CI , Financial) has delivered capital gains averaging 14.56% per year. Yes, the upward path has sometimes been bumpy, but the trajectory kept taking it higher.

Cigna: Capital Gains and Reliable Growth

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Is Cigna (CI) a Great Value Stock Right Now?

Cigna (CI) & Oscar Health's plans are likely to target businesses with 1-50 employees.

Cigna (CI) & Oscar Health Boost Presence in Philadelphia

Oscar Health

PHILADELPHIA & NEW YORK--(BUSINESS WIRE)--Cigna Corporation (NYSE: CI), a leading global health service company, and Oscar Health, Inc. (“Oscar”) (NYSE: OSCR), the first health insurance company built on a full stack technology platform, announced that Cigna + Oscar2 small business health insurance will be available across the Philadelphia metro area, including Bucks, Chester, Delaware, Montgomery, and Philadelphia counties beginning January 1, 2023, pending regulatory approval. “A healthy work

Cigna + Oscar Expands Footprint to Bring Small Businesses in Philadelphia Access to Cost-Effective Health Plans

Cigna (CI) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Cigna Corporation (CI) Hits Fresh High: Is There Still Room to Run?

Here is how Cigna (CI) and Ashford (AINC) have performed compared to their sector so far this year.

Are Finance Stocks Lagging Cigna (CI) This Year?

AbbVie

Becton, Dickinson and Co.

DuPont de Nemours

JPMorgan Chase & Co

Pfizer

Buying high-quality blue-chip stocks in a bear market could be a solid path to generating lucrative long-term returns. Blue-chip stocks are typically large-cap businesses in the mature stage of their business cycle.

7 Blue-Chip Stocks That Will Survive 2022

Is Most-Watched Stock Cigna Corporation (CI) Worth Betting on Now?

American Tower

Estee Lauder

Elevance Health Inc

Prologis

S&P Global

Thermo Fisher Scientific

Zoetis

Institutional investors are big investors that generally buy shares on behalf of their clients or members.

These Are The Ten Biggest Companies With Over 90% Institutional Ownership

Diversified Healthcare Trust (DHC) Q2 2022 Earnings Conference Call August 4, 2022 8:30 AM ET Company Participants Ralph Giacobbe - Senior Vice President & Head of Investor Relations David Cordani - President & Chief Executive Officer Brian Evanko - Executive Vice President & Chief Financial Officer Conference Call Participants Matthew Borsch - BMO Capital Markets Kevin Fischbeck - Bank of America Josh Raskin - Nephron Research Dave Windley - Jefferies A.J. Rice - Credit Suisse Justin Lake - Wolfe Research Gary Taylor - Cowen Lisa Gill - JPMorgan Kevin Caliendo - UBS Nathan Rich - Goldman Sachs Stephen Baxter - Wells Fargo Steven Valiquette - Barclays Lance Wilkes - Bernstein George Hill - Deutsche Bank Ben Hendrix - RBC Capital Markets Operator Ladies and gentlemen, thank you for standing by for Cigna's Second Quarter 2022 Results Review.

News for Cigna Stock (CI)